Search clinical trials for: Aplidin (plitidepsin)

Total 26 results

PharmaMar

Completed

Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma

Lymphoma | Leukemia

Italy, France, Switzerland, Spain, Peru, Puerto Rico
PharmaMar

Terminated

A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma

Lymphoma

United States, Spain, Italy, Czechia
PharmaMar

Terminated

A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer

Prostate Cancer

United States
PharmaMar

Completed

Clinical Trial of Aplidin® in Patients With Primary Myelofibrosis

Myelofibrosis

United States, Italy
PharmaMar

Completed

Aplidin - Dexamethasone in Relapsed/Refractory Myeloma (ADMYRE)

Relapsed/Refractory Multiple Myeloma

United States, Australia, Austria, Belgium, Czechia, France, Germany, Greece, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Spain, Taiwan, United Kingdom
PharmaMar
Apices Soluciones S.L.

Completed

Extension Study in a Cohort of Adult Patients With COVID-19 Infection (E-APLICOV-PC)

COVID-19 Infection

Spain
Institut Bergonié
Ministry of Health, France; PharmaMar

Terminated

Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial (APLIPO)

Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma

France
PharmaMar
Apices Soluciones S.L.

Completed

Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19 (APLICOV-PC)

COVID-19

Spain
PharmaMar

Terminated

Plitidepsin Versus Control in Immunocompromised Adult Participants With Symptomatic COVID-19 Requiring Hospital Care (NEREIDA)

COVID-19

Spain, Portugal, France, Belgium, Italy, Greece, Hungary, Georgia, Israel, Poland, United Kingdom
PharmaMar

Completed

A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma

Multiple Myeloma

United States
PharmaMar

Completed

Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas

Advanced Solid Tumors | Lymphomas

France, United States
Contego Medical, Inc.

Completed

A Multi-Center Study to Evaluate Acute Safety and Clinical Performance of Paladin® Carotid Post-Dilation Balloon System With Integrated Embolic Protection

Carotid Artery Stenoses

Germany
National Center for Complementary and Integrative...

Withdrawn

Garlic in Hyperlipidemia Caused by HAART

Hyperglycemia | HIV Infections | Hypercholesterolemia | Hypertriglyceridemia

United States
National Taiwan University Hospital

Completed

Investigating the Gut Microbiota Modulation Effects of Allicin for Cardiovascular Disease Protection and Establishing Microbiota Directed Personalized Nutrition Guidance With Novel Humanized Gnotobiotic Mice Model, Microbial Culturomics and Metabolomic Technique

Atherosclerosis

Taiwan
PharmaMar

Terminated

Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia

Relapsed/Refractory Leukemia

United States
Fred Hutchinson Cancer Center
National Center for Complementary and Integrative Health (NCCIH)

Completed

Effects of Garlic Supplements on Drug Metabolism

Healthy

United States
PharmaMar

Completed

Study of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma

Multiple Myeloma

Spain, France
PharmaMar

Terminated

Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and Lenalidomide

Multiple Myeloma

France, Spain, Italy
Istituto Scientifico Romagnolo per lo Studio e...

Not yet recruiting

Avidination for RadionuclideTHerapy in Nonpalpable Breast Cancer (ARTHE)

Breast Cancer
Sanofi

Completed

Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs (EQUINOX)

Deep Venous Thrombosis

France, Mexico, Turkey, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Denmark, Israel, Netherlands, New Zealand, Poland, Russian Federation, South Africa, Spain
Sanofi

Terminated

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation (BOREALIS-AF)

Atrial Fibrillation

South Africa, Thailand, Chile, Guatemala, Ukraine, United States, Argentina, Australia, Austria, Belarus, Brazil, Bulgaria, Canada, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Greece, India, ... and more
PharmaMar

Terminated

Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection (Neptuno)

COVID-19 Infection

Spain, Brazil, Romania, Bulgaria, Colombia, France, Greece, Mexico
Zhejiang University
Hangzhou Occupational Disease Prevention Hospital

Unknown

Three Measures for the Prevention of Carious Lesions in Preschool Children

Dental Caries

China
Oslo University Hospital
University of Oslo

Unknown

Dietary Intervention in Follicular Lymphoma (KLYMF)

Follicular Lymphoma

Norway
Sogo Rinsho Médéfi Co., Ltd.
Takeda

Completed

Azilsartan Circadian and Sleep Pressure

Hypertension

Japan
Sanofi

Completed

Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach (CASSIOPEA)

Embolism | Thrombosis

United States, France, Canada, Brazil, Poland, Ukraine, Italy, Netherlands, Portugal, Spain, Sweden, Turkey, Bulgaria, Estonia, India, Philippines, Belgium, Czech Republic, Mexico, Argentina, Croatia, Denmark, Egypt, Israel, Norway, United... and more

Search clinical trials for: Aplidin (plitidepsin)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations